Pictet Asset Management (Switzerland)’s Bristol-Myers Squibb BMY Stock Holding History

Pictet Asset Management (Switzerland)’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$67M	Sell	1,047,007 -16,325	-2%	-$1.09M	0.08%	254
2023 Q1	$73.7M	Buy	1,063,332 +19,516	+2%	+$1.38M	0.09%	234
2022 Q4	$64.6M	Buy	1,043,816 +21,926	+2%	+$1.65M	0.09%	234
2022 Q3	$72.6M	Sell	1,021,890 -13,160	-1%	-$955K	0.11%	224
2022 Q2	$79.7M	Sell	1,035,050 -30,761	-3%	-$2.34M	0.11%	217
2022 Q1	$77.8M	Buy	1,065,811 +26,121	+3%	+$1.75M	0.09%	251
2021 Q4	$64.8M	Buy	1,039,690 +10,562	+1%	+$620K	0.06%	301
2021 Q3	$60.9M	Buy	+1,029,128	New	+$67.8M	0.07%	300

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Pictet Asset Management (Switzerland)'s BMY Position: Q2 2023 in Review

Pictet Asset Management (Switzerland) reduced its Bristol-Myers Squibb (BMY) stake by 1.5% in Q2 2023, selling an estimated $1.09M and leaving 1,047,007 shares worth $67M. The position accounts for 0.08% of the portfolio, ranked #254.

Pictet Asset Management (Switzerland) first reported a position in BMY in Q3 2021 and has held it in 8 quarters since. The position peaked at $79.7M in Q2 2022. 2,481 funds tracked by Wall St. Rank hold BMY as of Q2 2023.

Pictet Asset Management (Switzerland) held 1,047,007 shares of Bristol-Myers Squibb worth $67M as of Q2 2023.
Pictet Asset Management (Switzerland) sold 16,325 Bristol-Myers Squibb shares in Q2 2023, an estimated $1.09M.
Bristol-Myers Squibb made up 0.08% of Pictet Asset Management (Switzerland)'s portfolio in Q2 2023, its #254 holding.
Pictet Asset Management (Switzerland) first reported a position in Bristol-Myers Squibb in Q3 2021 and has held it in 8 quarters since.
Pictet Asset Management (Switzerland)'s Bristol-Myers Squibb position peaked at $79.7M in Q2 2022.
2,481 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2023.

Based on Pictet Asset Management (Switzerland)'s 13F filing for Q2 2023, filed 10 Aug 2023.